• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

COG3

Peptic ulcer bleeding is certainly a significant medical problem with significant

December 20, 2018 by Katherine Lewis Leave a Comment

Peptic ulcer bleeding is certainly a significant medical problem with significant morbidity and mortality. 80 mg intravenous bolus accompanied by 8 mg/h for 3 d as well as the re-bleeding prices were also lower in the PPI group in comparison using the placebo group (Time 3: 5/120 24/120 0.001; Time 30: 8/120 27/120, 0.001). Alternatively, … [Read more…]

Posted in: Blogging Tagged: Baricitinib, COG3

Background This is an updated version of the original Cochrane review

August 20, 2017 by Katherine Lewis Leave a Comment

Background This is an updated version of the original Cochrane review first published in Issue 4, 2009. 2011 and searched the MetaRegister for ongoing trials. Selection criteria Randomised controlled trials (RCTs) that compared adjuvant therapies (radiotherapy, chemotherapy followed by radiotherapy, or chemoradiation) with no radiotherapy or chemoradiation, in women with a confirmed histological diagnosis of … [Read more…]

Posted in: Blogging Tagged: 606-04-2 IC50, COG3

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by